Asia-Pacific Proteomics Market Competitive Landscape: Growth Drivers, Revenue Analysis by 2028

Comments · 109 Views

The Asia-Pacific Proteomics Market is estimated to grow at a CAGR of around 7.8% during the forecast period, i.e., 2023-28.

MarkNtel Advisors, a leading market research firm, has showed its latest study titled "Asia-Pacific Proteomics Market", offering a detailed industry overview and market perspective. This comprehensive research provides insights into the current state of the market, highlighting recent advancements and emerging trends.

The report combines in-depth quantitative analysis with qualitative analysis; it ranges from macro-overviews of the overall market size, industry chain, and market dynamics to micro details of segment markets. This, as a result, provides a thorough overview of the industry under study as well as a profound understanding of all of its important features.

Analysis and Insights into the Asia-Pacific Proteomics Market: 2023-2028

The Asia-Pacific Proteomics Market size is estimated to grow at a CAGR of around 7.8% during the forecast period, i.e., 2023-28.

“In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecasts for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.”

Download the PDF Sample Copy (Including FULL TOC, Graphs, and Tables) of this Report - https://www.marknteladvisors.com/query/request-sample/apac-proteomics-market.html                          

What are the primary factors driving the growth of the Asia-Pacific Proteomics Market?

Asia-Pacific Proteomics Market Driver: Rising Need for New Drug Development Augmented the Demand for Proteomics Services

The rising prevalence of chronic diseases such as cancer, arthritis, chronic obstructive pulmonary disease, etc., across APAC, has been propelling pharmaceutical companies & biotech companies like Takeda, Pfizer, etc., to advance their research & development of new drugs & therapies.

As a result, the demand for proteomics services has increased since these testing services were used at various stages of drug development, such as preclinical testing, clinical trials, and others. Also, in recent years, to expedite the proteomics process various key technological developments have been observed, such as the inclusion of orbitrap mass spectrometry & protein microarrays. For instance:

In 2022, Thermofisher Scientific Inc. launched Q Exactive UHMR Hybrid Quadrupole-Orbitrap mass spectrometers, the first time equipped with charge detection capabilities, allowing direct mass determination of hundreds to thousands of individual ions in a single spectrum.

Moreover, advancements in proteomics have expanded the scope to develop novel therapeutic therapies in recent years. As a result, biotechnology companies like Merck, GE Healthcare, etc., are increasingly investing in the research and development of drugs, as well as adopting new technologies in proteomics. These investments and technological advancements are expected to accelerate the market growth of proteomic services in the forecast years.

Asia-Pacific Proteomics Market Segmentation:

The Asia-Pacific Proteomics Market is categorized in to different segments. Analyzing growth across these segments enables a comprehensive understanding of key growth areas within the industry. This segmentation provides valuable market insights, empowering stakeholders to make strategic decisions and identify primary market applications effectively.

By Technology

-Spectroscopy

--Mass Spectroscopy

--NMR Spectroscopy

--CD Spectroscopy

-Chromatography

--HPLC Chromatography

--Affinity Chromatography

--Supercritical Fluid Chromatography

--Ion Exchange Chromatography

-Electrophoresis

--Gel Electrophoresis

--Capillary Electrophoresis

--Protein Microarray

--Biochip

--Lab-on-Chip

-Protein Chip

--Microarray Instrument

---Integrated System

-Microarray Scanner

--Arrayers

-Crystallography

-Surface Plasma Resonance

-Fractionation

-Others (X-Ray Crystallography, Enzyme-linked Immunosorbent Assay, etc.)

  • The Spectroscopy segment held a sizeable share in the Asia-Pacific Proteomics Market. The Spectroscopy segment held a sizeable share of the Asia-Pacific Proteomics Market.

By Reagent

-Immunoassay Reagents

-Spectroscopy Reagents

-Chromatography Reagents

-Protein Microarray Reagents

-X-Ray Crystallography Reagents

-Electrophoresis Reagents

-Protein Fractionation Reagents

-Others (Glycobiology Agents, Phos-tag, etc.)

By Offering

-Core Proteomics Service

--Protein Identification

--Protein Characterization

--Quantitative proteomics

--Protein Purification

--Protein Separation

--Protein Sequencing

--Custom Assay

-Software & Services

--Bioinformatics Services

--Bioinformatics Tools

--Bioinformatics Database

By Indication

-Oncology

-Infectious Diseases

-Diabetes

-Neurological Disorder

-Autoimmune Diseases

-Cardiovascular Diseases

-Others (Gastrointestinal, Lung disease, etc.)

By End-User

-Hospitals

-Clinical Laboratories

-Pharmaceutical & Biotechnology Companies

-Academic Research Laboratories

Geographical Analysis into the Asia-Pacific Proteomics Market:

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Rest of the Asia-Pacific

Read Detailed Index of full Research Study at - https://www.marknteladvisors.com/research-library/apac-proteomics-market.html                                

Competitive Landscape and Asia-Pacific Proteomics Market Share Analysis:

The competitive landscape of the Asia-Pacific Proteomics Market includes comprehensive details about competitors. These details encompass company overviews, financial performance, revenue generation, market potential, investments in research and development, new market strategies, production facilities, strengths and weaknesses, product launches, ongoing trials, approvals, patents, product range, dominant applications, and technology life cycle.

The report features major players including:

Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, GE Healthcare, Thermofisher Scientific Inc., Merck KgaA, Promega Corporation, Bruker Corporation, Waters Corporation, MRM Proteomics Inc., Luminex Inc., Perkin Elmer Inc., and others

Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Questions Addressed in this Study

  • What factors are driving the Asia-Pacific Proteomics Market growth?
  • How is the Asia-Pacific Proteomics Market expected to grow over the next five years?
  • What are the key insights into the current trends in the Asia-Pacific Proteomics Market?
  • What is the current size of the Asia-Pacific Proteomics Market, and how is it projected to change in the future?
  • What is the future outlook for the Asia-Pacific Proteomics Market in terms of technological advancements and market expansion?

Why choose MarkNtel?

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 14.8 diverse industrial verticals.

Contact Us –

Call: ? +1 628 895 8081 +91 120 4278433

Email: ? sales@marknteladvisors.com

Visit to know more: ? https://www.marknteladvisors.com

Comments